Pay in 4 interest-free payments of $6.22 Learn more
Ships within 48 hours · Estimated delivery Aug 25 - Aug 30
A.PlovanichM
Each stack page includes a combined dosing table showing every compound's dose, frequency, route, and phase
In a recent meta-analysis of 12 observational studies of patients with T2DM treated with either SGLT2 inhibitors or GLP-1RAs, the GLP-1RA group exhibited a significantly lower relative risk of lower limb amputation vs the SGLT2 inhibitor cohort (3.54 vs 4.72 events per 1000 patient-years).37 Furthermore, in the CANVAS program involving 10,142 patients with T2DM at high cardiovascular risk, canagliflozin was found to be associated with a 1.97-fold increased risk of lower-limb amputations
Your doctors can assess your risk based on your medical and family history, lab results, and dietary habits (6)
US$ 20.15
US$ 24.07
US$ 25.08
